These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 8142196)

  • 1. Cardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure.
    Feng QP; Hedner T; Andersson B; Lundberg JM; Waagstein F
    Br Heart J; 1994 Mar; 71(3):261-7. PubMed ID: 8142196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Level of neuropeptide Y in serum of patients with chronic congestive heart failure].
    Halawa B
    Pol Arch Med Wewn; 1996 May; 95(5):427-32. PubMed ID: 8848410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma noradrenaline and neuropeptide-Y may not be of primary importance in the pathophysiology of cardiac involvement in systemic sclerosis.
    Kazzam E; Caidahl K; Hedner T; Hedner J; Waldenström A
    Scand J Rheumatol; 1999; 28(4):238-43. PubMed ID: 10503561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y, noradrenaline and invasive haemodynamic data in mild to moderate chronic congestive heart failure.
    Ullman B; Jensen-Urstad M; Hulting J; Lundberg JM
    Clin Physiol; 1993 Jul; 13(4):409-18. PubMed ID: 8370239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans.
    Morris MJ; Cox HS; Lambert GW; Kaye DM; Jennings GL; Meredith IT; Esler MD
    Hypertension; 1997 Jan; 29(1 Pt 1):137-43. PubMed ID: 9039093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma neuropeptide Y on admission to a coronary care unit: raised levels in patients with left heart failure.
    Hulting J; Sollevi A; Ullman B; Franco-Cereceda A; Lundberg JM
    Cardiovasc Res; 1990 Feb; 24(2):102-8. PubMed ID: 2328516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release of neuropeptide Y and noradrenaline from the human heart after aortic occlusion during coronary artery surgery.
    Franco-Cereceda A; Owall A; Settergren G; Sollevi A; Lundberg JM
    Cardiovasc Res; 1990 Mar; 24(3):242-6. PubMed ID: 2346958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship among neuropeptide Y, catecholamines and haemodynamics in congestive heart failure.
    Dubois-Randé JL; Comoy E; Merlet P; Benvenuti C; Carville C; Hittinger L; Macquin-Mavier I; Bohuon C; Castaigne A
    Eur Heart J; 1992 Sep; 13(9):1233-8. PubMed ID: 1396834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How does treatment influence endocrine mechanisms in acute severe heart failure? Effects on cardiac natriuretic peptides, the renin system, neuropeptide Y and catecholamines.
    Missouris CG; Grouzmann E; Buckley MG; Barron J; MacGregor GA; Singer DR
    Clin Sci (Lond); 1998 Jun; 94(6):591-9. PubMed ID: 9854456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical decrease in circulating neuropeptide Y-like immunoreactivity during mild orthostatic stress in subjects with and without congestive heart failure.
    Derchi G; Dupuis J; de Champlain J; Rouleau JL
    Eur Heart J; 1993 Jan; 14(1):34-9. PubMed ID: 8432288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of plasma neuropeptide Y and noradrenaline to dynamic exercise and ramipril treatment in patients with congestive heart failure.
    Ullman B; Lindvall K; Lundberg JM; Sigurdsson A; Swedberg K
    Clin Physiol; 1994 Mar; 14(2):123-34. PubMed ID: 8205743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous evaluation of left- and right-sided heart pumping function during dynamic leg exercise in patients with mild chronic congestive heart failure, with special reference to afterload and plasma noradrenaline.
    Minatoguchi S; Ito H; Asano K; Koshiji M; Uno Y; Kakami M; Yokoyama H; Fujiwara H
    Heart Vessels; 1997; 12(1):34-42. PubMed ID: 9288558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma immunoreactive neuropeptide Y in congestive heart failure at rest and during exercise.
    Madsen BK; Husum D; Videbaek R; Stokholm KH; Saelsen L; Christensen NJ
    Scand J Clin Lab Invest; 1993 Oct; 53(6):569-76. PubMed ID: 8266002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of neuropeptide Y upon haemorrhagic hypovolaemia in relation to vasoconstrictor effects in the pig.
    Rudehill A; Olcén M; Sollevi A; Hamberger B; Lundberg JM
    Acta Physiol Scand; 1987 Dec; 131(4):517-23. PubMed ID: 3442241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of plasma neuropeptide Y-like immunoreactivity and noradrenaline during myocardial ischaemia in man.
    Ullman B; Franco-Cereceda A; Hulting J; Lundberg JM; Sollevi A
    J Intern Med; 1990 Dec; 228(6):583-9. PubMed ID: 2280235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in plasma neuropeptide Y immunoreactivity and catecholamine levels during surgical removal of pheochromocytoma.
    Januszewicz W; Wocial B; Ignatowska-Switalska H; Dutkiewicz-Raczkowska M; Feltynowski T; Januszewicz A; Tapiński M; Zukowska-Grójec Z; Szostek M
    J Hypertens; 1998 Apr; 16(4):543-7. PubMed ID: 9797201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of work and acute beta-receptor blockade on myocardial noradrenaline release in congestive cardiomyopathy.
    Swedberg K; Hjalmarson A; Holmberg S
    Clin Cardiol; 1979 Dec; 2(6):424-30. PubMed ID: 44491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac outflow of endothelin, neuropeptide Y and noradrenaline in relation to hyperaemia in coronary sinus flow following electrical conversion of induced ventricular fibrillation in man.
    Runsiö M; Rosenqvist M; Bergfeldt L; Owall A; Lundberg JM; Franco-Cereceda A
    Eur Heart J; 1995 Dec; 16(12):1925-9. PubMed ID: 8682028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of endothelin-like immunoreactivity in relation to neuropeptide Y and catecholamines during endotoxin shock and asphyxia in the pig.
    Pernow J; Hemsén A; Hallén A; Lundberg JM
    Acta Physiol Scand; 1990 Nov; 140(3):311-22. PubMed ID: 2082700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased myocardial [123I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure.
    Somsen GA; van Vlies B; de Milliano PA; Borm JJ; van Royen EA; Endert E; Lie KI
    Heart; 1996 Sep; 76(3):218-22. PubMed ID: 8868979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.